Basel has 103 active pharma listings across 4 employers in the current snapshot. The snapshot is concentrated: 100 of the 103 come from Novartis, Roche and Lonza, with Syngenta supplying the remaining 3.
The useful questions are which employers appear, which functions those listings are classified under, and what the advertisements say about language.
Four employers, with three accounting for 100 of 103 listings
The 103 listings break down like this:
- Novartis — 49
- Roche — 32
- Lonza — 19
- Syngenta — 3
The employer breakdown is more revealing than the headline total: nearly the entire snapshot sits with three companies. A city-filtered snapshot of Basel is not the Basel labour market, and four employers is a narrow base worth stating plainly.
Research and development is the largest classified function
Grouping the 103 listings by classified function:
- Research & Development — 31
- Executive & Leadership — 18
- Engineering — 8
- IT & Digital — 6
- Finance & Legal — 6
- Quality Assurance — 5
- Clinical Research — 4
- and 11 further functions with 3 or fewer listings each, including Manufacturing (3), HR & Talent (3), Data Science (3) and Apprenticeship (3)
After R&D's 31 and Executive & Leadership's 18, no other function reaches double figures: the remaining 54 listings are distributed across the other 16 functions. R&D is a plurality, not a majority.
One classification note, from the taxonomy's own rules rather than from the payload. Executive & Leadership groups by job title, and titles such as "Director" or "Head of" can belong to senior individual contributors as well as to people managers. Read that bucket as a title-based grouping, not as a count of management roles.
Eleven functions sit at three listings or fewer in this snapshot. Counts in a set this size are point-in-time and may change when the snapshot is refreshed.
What the advertisements say about language
Of the 103 listings, 54 carry at least one classified language statement. The classification separates four kinds of statement, and the distinction is the point:
- required — 23
- preferred — 18
- mentioned — 35
- not required — 3
Split by language, among those 54:
- English — required in 16, preferred in 10, mentioned in 25, not required in 0
- German — required in 7, preferred in 7, mentioned in 10, not required in 1
- French — preferred in 1, not required in 1
- Italian — not required in 1
Two things follow, and neither supports a slogan. First, these are counts of classified statements, not counts of jobs in which a language is spoken — the same listing can state English and German, so the figures sum past 54. Second, "mentioned" is not "required". A listing that names German in passing has not said German is a condition of the role.
The reading is narrower than either "English is enough in Basel" or "German is mandatory in Basel". Some listings state a requirement explicitly, some treat it as an advantage, and some merely mention it. The classification describes what the advertisement says. It does not tell you which language an interview happens in, which one a team uses day to day, or how a hiring manager weighs it. The remaining 49 listings have no classified language statement in this dataset — and no conclusion about their language requirements can be drawn from that absence.
Salary transparency is too thin for a Basel benchmark
8 of the 103 listings show salary information. Those 8 yield an aggregate sample of 7 qualifying observations from 1 company, and that company accounts for 100% of them.
That is not a sample you can build a benchmark from, and Phirm's rule for publishing a market aggregate is explicit: at least 20 qualifying observations, at least 3 companies represented, and no single company contributing more than 60% of the observations. This sample fails all three, so no Basel salary median is reported here — not a range, not a midpoint, not a provisional figure.
The defensible finding is about disclosure, not pay levels: 8 of 103 listings show salary information at all, which is the number worth reading.
Examples from the current snapshot
These roles were active in the current snapshot; without source dates they cannot be ranked by recency, and they are not presented as representative:
- Disease Area Lead Neuroscience — Novartis, Research & Development
- Senior Legal Counsel, Global TechOps & Pharma Quality — Roche, Finance & Legal
- IT Business Partner, Integrated Biologics — Lonza, Data Science
- Senior Principal Scientist - Proteomics — Novartis, Research & Development
Browse the current Basel pharma jobs on Phirm.
About these numbers
This snapshot covers 103 active listings from four employers in Basel city on 12 September 2026. The wider Basel region is outside its scope. Language figures reflect statements in job advertisements, not the language the ads are written in.